1. Home
  2. RFL vs PLBY Comparison

RFL vs PLBY Comparison

Compare RFL & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • PLBY
  • Stock Information
  • Founded
  • RFL 2017
  • PLBY 1953
  • Country
  • RFL United States
  • PLBY United States
  • Employees
  • RFL N/A
  • PLBY N/A
  • Industry
  • RFL Real Estate
  • PLBY Recreational Games/Products/Toys
  • Sector
  • RFL Finance
  • PLBY Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • PLBY Nasdaq
  • Market Cap
  • RFL 55.3M
  • PLBY 142.4M
  • IPO Year
  • RFL N/A
  • PLBY N/A
  • Fundamental
  • Price
  • RFL $1.92
  • PLBY $1.65
  • Analyst Decision
  • RFL
  • PLBY Buy
  • Analyst Count
  • RFL 0
  • PLBY 2
  • Target Price
  • RFL N/A
  • PLBY $2.35
  • AVG Volume (30 Days)
  • RFL 30.6K
  • PLBY 841.0K
  • Earning Date
  • RFL 12-27-2024
  • PLBY 11-12-2024
  • Dividend Yield
  • RFL N/A
  • PLBY N/A
  • EPS Growth
  • RFL N/A
  • PLBY N/A
  • EPS
  • RFL N/A
  • PLBY N/A
  • Revenue
  • RFL $697,000.00
  • PLBY $124,761,000.00
  • Revenue This Year
  • RFL N/A
  • PLBY N/A
  • Revenue Next Year
  • RFL N/A
  • PLBY N/A
  • P/E Ratio
  • RFL N/A
  • PLBY N/A
  • Revenue Growth
  • RFL 151.62
  • PLBY 30.09
  • 52 Week Low
  • RFL $1.29
  • PLBY $0.52
  • 52 Week High
  • RFL $2.50
  • PLBY $1.99
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.58
  • PLBY 58.94
  • Support Level
  • RFL $1.71
  • PLBY $1.33
  • Resistance Level
  • RFL $1.92
  • PLBY $1.99
  • Average True Range (ATR)
  • RFL 0.10
  • PLBY 0.18
  • MACD
  • RFL -0.00
  • PLBY -0.00
  • Stochastic Oscillator
  • RFL 84.00
  • PLBY 50.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About PLBY PLBY Group Inc.

PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

Share on Social Networks: